Page 2 - Berndr Seizinger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Berndr seizinger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Berndr Seizinger Today - Breaking & Trending Today

Oncolytics Biotech : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 15, 2024 MANAGEMENT INFORMATION CIRCULAR - Form 6-K

NOTICE OF ANNUAL GENERAL MEETING

OF SHAREHOLDERS TO BE HELD ON MAY 15, 2024

- AND -

MANAGEMENT INFORMATION CIRCULAR

. ....

University Of Dayton , United States , New Jersey , United Kingdom , New York , Princeton University , Sanofi Pasteur , Angela Holtham , Laurel Hill , Broadridge Quickvote , Deborahm Brown , Thomasc Heineman , Jamest Parsons , Aptose Biosciences , Matthewc Coffey , Amyg Levin , Matt Coffey , Berndr Seizinger , Bernd Seizinger , Bristol Myers Squibb , Patricia Andrews , Allison Hagerman , Wayne Pisano , Revolo Biotherapeutics , Jonathan Rigby , Michael Bennett ,

Aprea Therapeutics, Inc. (NASDAQ:APRE) Expected to Post Q1 2025 Earnings of ($1.00) Per Share

Aprea Therapeutics, Inc. (NASDAQ:APRE – Free Report) – Stock analysts at Wedbush issued their Q1 2025 earnings per share estimates for shares of Aprea Therapeutics in a research note issued to investors on Tuesday, March 26th. Wedbush analyst R. Driscoll forecasts that the company will post earnings of ($1.00) per share for the quarter. Wedbush […] ....

Berndr Seizinger , Geode Capital Management , Securities Exchange Commission , Royal Bank , Aprea Therapeutics Inc , Millennium Management , Vanguard Group Inc , Aprea Therapeutics Company Profile , Aprea Therapeutics , Free Report , Aprea Therapeutic , Director Bernd , Exchange Commission , Capital Management , Get Free Report , Aprea Therapeutics Daily ,

Aprea Therapeutics (NASDAQ:APRE) Price Target Increased to $11.00 by Analysts at Wedbush

Aprea Therapeutics (NASDAQ:APRE – Free Report) had its price target boosted by Wedbush from $9.00 to $11.00 in a research note issued to investors on Wednesday morning, Benzinga reports. The firm currently has an outperform rating on the stock. Separately, HC Wainwright restated a buy rating and issued a $20.00 price target on shares of […] ....

Berndr Seizinger , Aprea Therapeutics Inc , Royal Bank , Geode Capital Management , Millennium Management , Vanguard Group Inc , Renaissance Technologies , Securities Exchange Commission , Aprea Therapeutics , Free Report , Therapeutics Stock Down , Director Bernd , Exchange Commission , Capital Management , Get Free Report , Aprea Therapeutics Daily , Nasdaq Apre , Boost Price Target ,

Aptose Biosciences Inc. (NASDAQ:APTO) Receives Consensus Recommendation of "Buy" from Brokerages

Aptose Biosciences Inc. (NASDAQ:APTO) Receives Consensus Recommendation of "Buy" from Brokerages
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Aptose Biosciences , Berndr Seizinger , Millennium Management , Aptose Biosciences Company Profile , Cantor Fitzgerald , Renaissance Technologies , Annandale Capital , Royal Bank , Securities Exchange Commission , Sigma Planning Corp , Aptose Biosciences Inc , Get Free Report , Director Bernd , Exchange Commission , Biosciences Stock Down , Get Free , Biosciences Inc , Aptose Biosciences Daily ,

Aptose Biosciences (NASDAQ:APTO) Upgraded to "Hold" at StockNews.com

StockNews.com upgraded shares of Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) from a sell rating to a hold rating in a research note issued to investors on Monday. APTO has been the topic of several other reports. HC Wainwright increased their target price on Aptose Biosciences from $12.00 to $23.00 and gave the stock a […] ....

Piper Sandler , Berndr Seizinger , Aptose Biosciences , Cantor Fitzgerald , Renaissance Technologies , Aptose Biosciences Inc , Cetera Advisors , Sequoia Financial Advisors , Millennium Management , Royal Bank , Annandale Capital , Free Report , Moderate Buy , Director Bernd , Financial Advisors , Get Free Report , Biosciences Inc , Aptose Biosciences Daily , Nasdaq Apto , Stocknews Com ,